Keratinocyte DNA

Keratinocyte DNA refers to the complete set of genetic material contained within keratinocytes, the primary structural cells of the epidermis. It functions as the essential template for the synthesis of proteins required for skin barrier formation, such as keratins and filaggrin, and regulates the complex process of epidermal differentiation and turnover (Source: NIH). In clinical dermatology, keratinocyte DNA is a critical site of pathology, as cumulative damage from ultraviolet (UV) radiation leads to the formation of mutagenic photoproducts like cyclobutane pyrimidine dimers. These mutations are the primary drivers for the development of actinic keratosis and non-melanoma skin cancers, including basal cell and squamous cell carcinomas (Source: PubMed). While not a specific protein target, it is the functional focus of several therapeutic strategies aimed at treating skin malignancies and hyperproliferative disorders. For example, topical 5-fluorouracil acts as an antimetabolite that disrupts DNA synthesis in rapidly dividing precancerous cells to induce cell death (Source: PubChem). Photodynamic therapy also targets this entity by inducing oxidative DNA damage to trigger apoptosis in diseased tissue (Source: FDA). Additionally, research into DNA repair enzymes, such as T4 endonuclease V, aims to enhance the natural repair mechanisms of the keratinocyte genome to prevent cancer (Source: Journal of Investigative Dermatology). Despite its therapeutic relevance, the term is generally considered too broad for modern drug discovery, which typically focuses on discrete molecular targets like enzymes or receptors.

Other names

Epidermal DNAKeratinocyte genomic DNA

Inhibition of DNA synthesis, induction of DNA damage-mediated apoptosis, or enhancement of enzymatic DNA repair (Source: PubChem, PubMed).